Interventional Neuroradiologic Therapy

Stroke: Pathophysiology, Diagnosis, and Management

Volumn , Issue , 2004, Pages 1475-1520

  Levy, Elad I ^a   Kim, Stanley H ^b   Bendok, Bernard R ^c   Boulos, Alan S ^d   Xavier, Andrew R ^e,f   Yahia, Abutaher M ^e   Qureshi, Adnan I ^e,f   Guterman, Lee R ^g   Hopkins, L Nelson ^g  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f NEUROLOGICAL INSTITUTE OF NEW JERSEY   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749578193     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-44-306600-0/50087-0     Document Type: Chapter

References (305)

1. Gibbons KJ, Livingston K Patient management, complications, and intensive care. Neurosurg Clin North Am 1994, 5:555-563.
2. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: A meta-analytical approach. Neurosurgery 1999, 45:539-548.
3. Jevtovic-Todorovic V, Wozniak DF, Powell S, Olney JW Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex. Brain Res 2001, 913:185-189.
4. Cooper KR, Boswell PA, Choi SC Safe use of PEEP in patients with severe head injury. J Neurosurg 1985, 63:552-555.
5. Cotev S, Paul WL, Ruiz BC, et al. Positive end-expiratory pressure (PEEP) and cerebrospinal fluid pressure during normal and elevated intracranial pressure in dogs. Intensive Care Med 1981, 7:187-191.
6. Chamorro A, Vila N, Ascaso C, et al. Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998, 29:1850-1853.
7. Davalos A, Cendra E, Teruel J, et al. Deteriorating ischemic stroke: Risk factors and prognosis. Neurology 1990, 40:1865-1869.
8. Goldstein LB Should antihypertensive therapies be given to patients with acute ischemic stroke?. Drug Safety 2000, 22:13-18.
9. Sagara Y, Hendler S, Khoh-Reiter S, et al. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999, 73:2524-2530.
10. Hornig CR, Haberbosch W, Lammers C, et al. Specific cardiological evaluation after focal cerebral ischemia. Acta Neurol Scand 1996, 93:297-302.
11. Stirling J, Muramatsu K, Shirai T Cerebral embolism as a cause of stroke and transient ischemic attack. Echocardiography 1996, 13:513-518.
12. Sancak T, Bilgic S, Sanldilek U Gadodiamide as an alternative contrast agent in intravenous digital subtraction angiography and interventional procedures of the upper extremity veins. Cardiovasc Intervent Radiol 2002, 25:49-52.
13. Madyoon H, Croushore L, Weaver D, Mathur V Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc Interv 2001, 53:341-345.
14. Goldstein LB, Samsa GP Reliability of the National Institutes of Health Stroke Scale: Extension to non-neurologists in the context of a clinical trial. Stroke 1997, 28:307-310.
15. Tomsick T, Brott T, Barsan W, et al. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol 1996, 17:79-85.
16. Campeau L Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn 1989, 16:3-7.
17. Spaulding C, Lefevre T, Funck F, et al. Left radial approach for coronary angiography: Results of a prospective study. Cathet Cardiovasc Diagn 1996, 39:365-370.
18. Lotan C, Hasin Y, Mosseri M, et al. Transradial approach for coronary angiography and angioplasty. Am J Cardiol 1995, 76:164-167.
19. Lotan C, Hasin Y, Salmoirago E, et al. The radial artery: An applicable approach to complex coronary angioplasty. J Invasive Cardiol 1997, 9:518-522.
20. Wu SS, Galani RJ, Bahro A, et al. 8 French transradial coronary interventions: Clinical outcome and late effects on the radial artery and hand function. J Invasive Cardiol 2000, 12:605-609.
21. Allen EV Thromboangiitis obliterans: Methods of diagnosis of chronic occlusive arterial lesions distal to the wrist with illustrative cases. Am J Med Sci 1929, 178:237-244.
22. Levy EI, Boulos AS, Fessler RD, et al. Transradial cerebral angiography: An alternative route. Neurosurgery 2002, 51:335-342.
23. Matsumoto Y, Hokama M, Nagashima H, et al. Transradial approach for selective cerebral angiography: Technical note. Neurol Res 2000, 22:605-608.
24. Matsumoto Y, Hongo K, Toriyama T, et al. Transradial approach for diagnostic selective cerebral angiography: Results of a consecutive series of 166 cases. AJNR Am J Neuroradiol 2001, 22:704-708.
25. Tissue plasminogen activator for acute ischemic stroke.The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 1995, 333:1581-1587.
26. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000, 283:1145-1150.
27. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245-1251.
28. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke.Multicentre Acute Stroke Trial-Italy (MAST-I) Group Lancet 1995, 346:1509-1514.
29. Thrombolytic therapy with streptokinase in acute ischemic stroke.The Multicenter.Acute Stroke Trial-Europe Study Group N Engl J Med 1996, 335:145-150.
30. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999, 282:2019-2026.
31. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA 1996, 276:961-966.
32. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995, 274:1017-1025.
33. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998, 29:4-11.
34. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282:2003-2011.
35. Eckert B, Koch C, Thomalla G, et al. Acute basilar artery occlusion treated with combined intravenous abciximab and intra-arterial tissue plasminogen activator: Report of 3 cases. Stroke 2002, 33:1424-1427.
36. Endo S, Kuwayama N, Hirashima Y, et al. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical internal carotid artery. AJNR Am J Neuroradiol 1998, 19:1169-1175.
37. Jahan R, Duckwiler GR, Kidwell CS, et al. Intraarterial thrombolysis for treatment of acute stroke: Experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999, 20:1291-1299.
38. Kim SH, Qureshi AI, Suri MFK, et al. Mechanical thrombolysis using balloon angioplasty and snare with low-dose intraarterial reteplase (third-generation thrombolytic) for ischemic stroke: A prospective study (paper 13). J Neurosurg 2002, 96:168A.
39. Nesbit GM, Clark WM, O'Neill OR, Barnwell SL Intracranial intraarterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery. J Neurosurg 1996, 84:387-392.
40. Qureshi AI, Suri MF, Shatla AA, et al. Intraarterial recombinant tissue plasminogen activator for ischemic stroke: An accelerating dosing regimen. Neurosurgery 2000, 47:473-479.
41. Qureshi AI, Ali Z, Suri MF, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001, 49:41-50.
42. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47:462-469.
43. Kidwell CS, Saver JL, Mattiello J, et al. Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans. Neurology 2001, 57:2015-2021.
44. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: An emerging application. Stroke 2002, 33:95-98.
45. Lev MH, Segal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intrarterial thrombolysis: Prediction of final infarct volume and clinical outcome. Stroke 2001, 32:2021-2028.
46. Qureshi AI, Ringer AJ, Suri MF, et al. Acute interventions for ischemic stroke: Present status and future directions. J Endovasc Ther 2000, 7:423-428.
47. Davydov L, Cheng JW Tenecteplase: A review. Clin Ther 2001, 23:982-997.
48. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987, 75:817-829.
49. Ernst R, Pancioli A, Tomsick T, et al. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 2000, 31:2552-2557.
50. Hill MD, Barber PA, Demchuk AM, et al. Acute intravenous-intra-arterial revascularization therapy for severe ischemic stroke. Stroke 2002, 33:279-282.
51. Keris V, Rudnicka S, Vorona V, et al. Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001, 22:352-358.
52. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598-2605.
53. Suarez JI, Zaidat OO, Sunshine JL, et al. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002, 50:251-260.
54. Broderick J: The Interventional Management of Stroke (IMS) Study: Preliminary results. Presented at The 7th International Symposium on Thrombolysis and Acute Stroke Therapy, Lyon, France, May 29-June 1, 2002.
55. Qureshi AI New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002, 50:1405-1415.
56. Chalela JA, Katzan I, Liebeskind DS, et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke 2001, 32:1365-1369.
57. Katzan IL, Masaryk TJ, Furlan AJ, et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 1999, 52:1081-1084.
58. Moazami N, Smedira NG, McCarthy PM, et al. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. Ann Thorac Surg 2001, 72:1933-1939.
59. Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I: Pathophysiological and pharmacological features. Neurosurgery 2000, 46:1344-1359.
60. Hill MD, Barber PA, Takahashi J, et al. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000, 162:1281-1284.
61. Rudolf J, Grond M, Schmulling S, et al. Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. Neurology 2000, 55:599-600.
62. Mericle RA, Lopes DK, Fronckowiak MD, et al. A grading scale to predict outcomes after intra-arterial thrombolysis for stroke complicated by contrast extravasation. Neurosurgery 2000, 46:1307-1315.
63. Mahaffey KW, Granger CB, Sloan MA, et al. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. Am Heart J 1999, 138:493-499.
64. Haley EC, Brott TG, Sheppard GL, et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group. Stroke 1993, 24:1000-1004.
65. Levy DE, Brott TG, Haley EC, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994, 25:291-297.
66. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial. Neurology 2001, 57:1603-1610.
67. Kidwell CS, Saver JL, Carneado J, et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002, 33:717-724.
68. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30:2094-2100.
69. Tanne D, Kasner SE, Demchuk AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The Multicenter rt-PA Stroke Survey. Circulation 2002, 105:1679-1685.
70. Ueda T, Sakaki S, Kumon Y, Ohta S Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30:2360-2365.
71. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001, 48:1282-1290.
72. Ueda T, Sakaki S, Nochide I, et al. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998, 29:2568-2574.
73. Starkman S, Gobin P, Duckwiler GR et al: Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial. Presented at The 27th International Stroke Conference. San Antonio, TX, The American Stroke Association, February 7-9, 2002.
74. Yahia AM, Qureshi AI, Boulos AS et al: Balloon-expandable stents for intracranial arterial occlusion in patients with ischemic stroke. Presented at The 7th International Symposium on Thrombolysis and Acute Stroke Therapy, Lyon, France, May 29-June 1, 2002.
75. Barnwell SL, Clark WM, Nguyen TT, et al. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol 1994, 15:1817-1822.
76. Chopko BW, Kerber C, Wong W, Georgy B Transcatheter snare removal of acute middle cerebral artery thromboembolism: Technical case report. Neurosurgery 2000, 46:1529-1531.
77. Teal PA, Hill MD, Alastair BM: Intra-arterial ultrasound catheter (EKOS) facilitated thrombolysis. Presented at The 7th International Symposium on Thrombolysis and Acute Stroke Therapy. Lyon, France, May 29-June 1, 2002.
78. Watson BD, Prado R, Veloso A, et al. Cerebral blood flow restoration and reperfusion injury after ultraviolet laser-facilitated middle cerebral artery recanalization in rat thrombotic stroke. Stroke 2002, 33:428-434.
79. Lutsep HL, Clark WM, Nesbit GM, et al. Intraarterial suction thrombectomy in acute stroke. AJNR Am J Neuroradiol 2002, 23:783-786.
80. Sharafuddin MJ, Hicks ME, Jenson ML, et al. Rheolytic thrombectomy with use of the AngioJet-F105 catheter: Preclinical evaluation of safety. J Vasc Interv Radiol 1997, 8:939-945.
81. Sacco RL, Kargman DE, Gu Q, Zamanillo MC Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995, 26:14-20.
82. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996, 27:1974-1980.
83. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995, 45:1488-1493.
84. Redman AR, Allen LC Warfarin Versus Aspirin in the Secondary Prevention of Stroke: The WARSS Study. Curr Atheroscler Rep 2002, 4:319-325.
85. The EC-IC bypass study. N Engl J Med 1987, 317:1030-1032.
86. Craig DR, Meguro K, Watridge C, et al. Intracranial internal carotid artery stenosis. Stroke 1982, 13:825-828.
87. Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: Long-term prognosis. Stroke 1982, 13:821-824.
88. Gorter JW Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999, 53:1319-1327.
89. Stroke Prevention in Atrial Fibrillation Study Final results. Circulation 1991, 84:527-539.
90. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994, 154:1449-1457.
91. Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1989, 8631:175-179.
92. Thijs VN, Albers GW Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 2000, 55:490-497.
93. Akins PT, Pilgram TK, Cross DT, Moran CJ Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke 1998, 29:433-438.
94. Callahan AS, Berger BL, Beuter MJ, Devlin TG Possible short-term amelioration of basilar plaque by high-dose atorvastatin: Use of reductase inhibitors for intracranial plaque stabilization. J Neuroimaging 2001, 11:202-204.
95. Ozgur HT, Kent Walsh T, Masaryk A, et al. Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol 2001, 22:928-936.
96. Webster MW, Makaroun MS, Steed DL, et al. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995, 21:338-345.
97. Yonas H, Pindzola RR, Meltzer CC, Sasser H Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 1998, 42:1005-1012.
98. Caplan LR, Hennerici M Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998, 55:1475-1482.
99. Awad IA, Little JR, Furlan AJ Conversion of an intracranial arterial stenosis to a symptomatic occlusion after EC/IC bypass surgery. Neurosurgery 1983, 13:734.
100. Awad I, Furlan AJ, Little JR Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg 1984, 60:771-776.
101. Clark WM, Barnwell SL, Nesbit G, et al. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995, 26:1200-1204.
102. Higashida RT, Tsai FY, Halbach VV, et al. Interventional neurovascular techniques in the treatment of stroke state-of-the-art therapy. J Intern Med 1995, 237:105-115.
103. Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: Experience and complications. AJNR Am J Neuroradiol 1997, 18:1661-1668.
104. Terada T, Higashida RT, Halbach VV, et al. Transluminal angioplasty for arteriosclerotic disease of the distal vertebral and basilar arteries. J Neurol Neurosurg Psychiatry 1996, 60:377-381.
105. Connors JJ, Wojak JC Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 1999, 91:415-423.
106. Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999, 30:1065-1069.
107. Mori T, Fukuoka M, Kazita K, Mori K Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998, 19:1525-1533.
108. Nahser HC, Henkes H, Weber W, et al. Intracranial vertebrobasilar stenosis: Angioplasty and follow-up. AJNR Am J Neuroradiol 2000, 21:1293-1301.
109. Mori T, Kazita K, Mori K Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol 1999, 20:787-789.
110. Mori T, Mori K, Fukuoka M, et al. Percutaneous transluminal cerebral angioplasty: Serial angiographic follow-up after successful dilatation. Neuroradiology 1997, 39:111-116.
111. George CJ, Baim DS, Brinker JA, et al. One-year follow-up of the Stent Restenosis (STRESS I) Study. Am J Cardiol 1998, 81:860-865.
112. Huang P, Levin T, Kabour A, Feldman T Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5mm) coronary arteries. Catheter Cardiovasc Interv 2000, 49:121-126.
113. Morice MC, Bradai R, Lefevre T, et al. Stenting small coronary arteries. J Invasive Cardiol 1999, 11:337-340.
114. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000, 31:95-99.
115. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: Early results. Neurosurgery 2001, 48:1215-1223.
116. Mori T, Kazita K, Chokyu K, et al. Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol 2000, 21:249-254.
117. Ramee SR, Dawson R, McKinley KL, et al. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: Acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv 2001, 52:457-467.
118. Lang J Clinical Anatomy of Brainstem Vessels 1981, Miles Pharmaceutical, New Haven, Conn.
119. Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar stenosis. J Neurosurg 2002, 97:1294-1301.
120. Fessler RD, Lanzino G, Guterman LR, et al. Improved cerebral perfusion after stenting of a petrous carotid stenosis: Technical case report. Neurosurgery 1999, 45:638-642.
121. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991, 325:445-453.
122. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998, 339:1415-1425.
123. Randomised trial of endarterectomy for recently symptomatic carotid stenosis. Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998, 351:1379-1387.
124. Study design for randomized prospective trial of carotid endarterectomy for asymptomatic atherosclerosis.The Asymptomatic Carotid Atherosclerosis Study Group Stroke 1989, 20:844-849.
125. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995, 273:1421-1428.
126. Young B, Moore WS, Robertson JT, et al. An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. Stroke 1996, 27:2216-2224.
127. Hobson RWI, Weiss DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis (Veterans Affairs Cooperative Study Group). N Engl J Med 1993, 328:221-227.
128. Morgenstern LB, Fox AJ, Sharpe BL, et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 1997, 48:911-915.
129. Kappelle LJ, Eliasziw M, Fox AJ, et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trial. Stroke 1999, 30:282-286.
130. Paciaroni M, Eliasziw M, Kappelle LJ, et al. Medical complications associated with carotid endarterectomy. North American Symptomatic Carotid Endarterectomy Trial (NASCET). Stroke 1999, 30:1759-1763.
131. Gray WA, White HJ, Barrett DM, et al. Carotid stenting and endarterectomy: A clinical and cost comparison of revascularization strategies. Stroke 2002, 33:1063-1070.
132. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000, 50:160-167.
133. Roubin GS, Hobson RW, White R, et al. CREST and CARESS to evaluate carotid stenting: Time to get to work. J Endovasc Ther 2001, 8:107-110.
134. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: A 5-year prospective analysis. Circulation 2001, 103:532-537.
135. Lopes DK, Mericle RA, Lanzino G, et al. Stent placement for the treatment of occlusive atherosclerotic carotid artery disease in patients with concomitant coronary artery disease. J Neurosurg 2002, 96:490-496.
136. Moore WS, Barnett HJ, Beebe HG, et al. Guidelines for carotid endarterectomy: A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 1995, 91:566-579.
137. New G, Roubin GS, Iyer SS, et al. Safety, efficacy, and durability of carotid artery stenting for restenosis following carotid endarterectomy: A multicenter study. J Endovasc Ther 2000, 7:345-352.
138. Hernandez-Vila E, Strickman NE, Skolkin M, et al. Carotid stenting for post-endarterectomy restenosis and radiation-induced occlusive disease. Tex Heart Inst J 2000, 27:159-165.
139. Paniagua D, Howell M, Strickman N, et al. Outcomes following extracranial carotid artery stenting in high-risk patients. J Invasive Cardiol 2001, 13:375-381.
140. Al-Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 2001, 104:1999-2002.
141. Angelini A, Reimers B, Della Barbera M, et al. Cerebral protection during carotid artery stenting: Collection and histopathologic analysis of embolized debris. Stroke 2002, 33:456-461.
142. Ohki T, Roubin GS, Veith FJ, et al. Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysis. J Vasc Surg 1999, 30:1034-1044.
143. Ohki T, Veith FJ Carotid artery stenting: Utility of cerebral protection devices. J Invasive Cardiol 2001, 13:47-55.
144. Ohki T, Parodi J, Veith FJ, et al. Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: An experimental analysis. J Vasc Surg 2001, 33:504-509.
145. Roubin GS The status of carotid stenting. AJNR Am J Neuroradiol 1999, 20:1378-1381.
146. Vitek JJ, Roubin GS, Al-Mubarek N, et al. Carotid artery stenting: Technical considerations. AJNR Am J Neuroradiol 2000, 21:1736-1743.
147. Wholey MH, Wholey M, Bergeron P, et al. Current global status of carotid artery stent placement. Cathet Cardiovasc Diagn 1998, 44:1-6.
148. Al-Mubarak N, Vitek JJ, Iyer SS, et al. Carotid stenting with distal-balloon protection via the transbrachial approach. J Endovasc Ther 2001, 8:571-575.
149. Al-Mubarak N, Vitek JJ, Iyer S, et al. Embolization via collateral circulation during carotid stenting with the distal balloon protection system. J Endovasc Ther 2001, 8:354-357.
150. Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001, 104:12-15.
151. Meyer FB, Sundt TM, Piepgras DG, et al. Emergency carotid endarterectomy for patients with acute carotid occlusion and profound neurological deficits. Ann Surg 1986, 203:82-89.
152. Blaisdell WF, Clauss RH, Galbraith JG, et al. Joint study of extracranial arterial occlusion. IV: A review of surgical considerations. JAMA 1969, 209:1889-1895.
153. Uno M, Hamazaki F, Kohno T, et al. Combined therapeutic approach of intra-arterial thrombolysis and carotid endarterectomy in selected patients with acute thrombotic carotid occlusion. J Vasc Surg 2001, 34:532-540.
154. Malek AM, Higashida RT, Phatouros CC, et al. Endovascular management of extracranial carotid artery dissection achieved using stent angioplasty. AJNR Am J Neuroradiol 2000, 21:1280-1292.
155. El Gindi S, Salama M, Tawfik E, et al. A review of 2,000 patients with craniocerebral injuries with regard to intracranial haematomas and other vascular complications. Acta Neurochir 1979, 48:237-244.
156. Burke JP, Marion DW Cerebral revascularization in trauma and carotid occlusion. Neurosurg Clin North Am 2001, 12:595-611.
157. Schievink WI, Mokri B, Whisnant JP Internal carotid artery dissection in a community: Rochester, Minnesota, 1987-1992. Stroke 1993, 24:1678-1680.
158. Bogousslavsky J, Regli F Ischemic stroke in adults younger than 30 years of age: Cause and prognosis. Arch Neurol 1987, 44:479-482.
159. Yamada S, Kindt GW, Youmans JR Carotid artery occlusion due to nonpenetrating injury. J Trauma 1967, 7:333-342.
160. Guillon B, Levy C, Bousser MG Internal carotid artery dissection: An update. J Neurol Sci 1998, 153:146-158.
161. Coffin O, Maiza D, Galateau-Salle F, et al. Results of surgical management of internal carotid artery aneurysm by the cervical approach. Ann Vasc Surg 1997, 11:482-490.
162. Treiman GS, Treiman RL, Foran RF, et al. Spontaneous dissection of the internal carotid artery: A nineteen-year clinical experience. J Vasc Surg 1996, 24:597-607.
163. Krajewski LP, Hertzer NR Blunt carotid artery trauma: Report of two cases and review of the literature. Ann Surg 1980, 191:341-346.
164. Liu AY, Paulsen RD, Marcellus ML, et al. Long-term outcomes after carotid stent placement treatment of carotid artery dissection. Neurosurgery 1999, 45:1368-1374.
165. Cloft HJ, Jensen ME, Kallmes DF, Dion JE Arterial dissections complicating cerebral angiography and cerebrovascular interventions. AJNR Am J Neuroradiol 2000, 21:541-545.
166. Hosoya T, Watanabe N, Yamaguchi K, et al. Intracranial vertebral artery dissection in Wallenberg syndrome. AJNR Am J Neuroradiol 1994, 15:1161-1165.
167. Dorros G, Cohn JM, Palmer LE Stent deployment resolves a petrous carotid artery angioplasty dissection. AJNR Am J Neuroradiol 1998, 19:392-394.
168. Kurata A, Ohmomo T, Miyasaka Y, et al. Coil embolization for the treatment of ruptured dissecting vertebral aneurysms. AJNR Am J Neuroradiol 2001, 22:11-18.
169. Yamaura A, Watanabe Y, Saeki N Dissecting aneurysms of the intracranial vertebral artery. J Neurosurg 1990, 72:183-188.
170. Aenis M, Stancampiano AP, Wakhloo AK, Lieber BB Modeling of flow in a straight stented and nonstented side wall aneurysm model. J Biomech Eng 1997, 119:206-212.
171. Imbesi SG, Kerber CW Analysis of slipstream flow in a wide-necked basilar artery aneurysm: Evaluation of potential treatment regimens. AJNR Am J Neuroradiol 2001, 22:721-724.
172. Kerber CW, Heilman CB Flow in experimental berry aneurysms: Method and model. AJNR Am J Neuroradiol 1983, 4:374-377.
173. Kerber CW, Cromwell LD, Zanetti PH Experimental carotid aneurysms. Part 2: Endovascular treatment with cyanoacrylate. Neurosurgery 1985, 16:13-17.
174. Kerber CW, Liepsch D Flow dynamics for radiologists. II: Practical considerations in the live human. AJNR Am J Neuroradiol 1994, 15:1076-1086.
175. Kerber CW, Liepsch D Flow dynamics for radiologists. I: Basic principles of fluid flow. AJNR Am J Neuroradiol 1994, 15:1065-1075.
176. Horowitz MB, Miller G, Meyer Y, et al. Use of intravascular stents in the treatment of internal carotid and extracranial vertebral artery pseudoaneurysms. AJNR Am J Neuroradiol 1996, 17:693-696.
177. Levy EI, Boulos AS, Bendok BR, et al. Brainstem infarction after delayed thrombosis of a stented vertebral artery fusiform aneurysm: Case report. Neurosurgery 2002, 51:1284-1285.
178. Heesch CM, Wilhelm CR, Ristich J, et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 2000, 83:688-695.
179. Terada T, Nakai E, Tsuura M, et al. Combined surgery and endovascular stenting for basilar artery stenosis refractory to balloon angioplasty: Technical case report. Acta Neurochir 2001, 143:511-516.
180. Horowitz MB, Levy EI, Koebbe CJ, Jungreis CC Transluminal stent-assisted coil embolization of a vertebral confluence aneurysm: Technique report. Surg Neurol 2001, 55:291-296.
181. Massoud TF, Turjman F, Ji C, et al. Endovascular treatment of fusiform aneurysms with stents and coils: Technical feasibility in a swine model. AJNR Am J Neuroradiol 1995, 16:1953-1963.
182. Phatouros CC, Sasaki TY, Higashida RT, et al. Stent-supported coil embolization: The treatment of fusiform and wide-neck aneurysms and pseudoaneurysms. Neurosurgery 2000, 47:107-115.
183. Phatouros CC, Higashida RT, Malek AM, et al. Endovascular treatment of noncarotid extracranial cerebrovascular disease. Neurosurg Clin North Am 2000, 11:331-350.
184. Wityk RJ, Chang HM, Rosengart A, et al. Proximal extracranial vertebral artery disease in the New England Medical Center Posterior Circulation Registry. Arch Neurol 1998, 55:470-478.
185. Caplan LR, Amarenco P, Rosengart A, et al. Embolism from vertebral artery origin occlusive disease. Neurology 1992, 42:1505-1512.
186. Gomez CR, Cruz-Flores S, Malkoff MD, et al. Isolated vertigo as a manifestation of vertebrobasilar ischemia. Neurology 1996, 47:94-97.
187. Rocha-Singh K Vertebral artery stenting: Ready for prime time?. Catheter Cardiovasc Interv 2001, 54:6-7.
188. Crawley F, Brown MM, Clifton AG Angioplasty and stenting in the carotid and vertebral arteries. Postgrad Med J 1998, 74:7-10.
189. Drescher P, Katzen BT Percutaneous treatment of symptomatic vertebral artery stenosis with coronary stents. Catheter Cardiovasc Interv 2001, 52:373-377.
190. Storey GS, Marks MP, Dake M, et al. Vertebral artery stenting following percutaneous transluminal angioplasty: Technical note. J Neurosurg 1996, 84:883-887.
191. Chastain HD, Campbell MS, Iyer S, et al. Extracranial vertebral artery stent placement: In-hospital and follow-up results. J Neurosurg 1999, 91:547-552.
192. Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993, 78:192-198.
193. Jenkins JS, White CJ, Ramee SR, et al. Vertebral artery stenting. Catheter Cardiovasc Interv 2001, 54:1-5.
194. Malek AM, Higashida RT, Phatouros CC, et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 1999, 30:2073-2085.
195. Mukherjee D, Roffi M, Kapadia SR, et al. Percutaneous intervention for symptomatic vertebral artery stenosis using coronary stents. J Invasive Cardiol 2001, 13:363-366.
196. Piotin M, Spelle L, Martin JB, et al. Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. AJNR Am J Neuroradiol 2000, 21:727-731.
197. Contorni L Il circolo collaterale vertebro-vertebrale nella obliterazione dell'arterio subclavia all sua origine. Minerva Chir 1960, 15:268-271.
198. Fisher C A new vascular syndrome: "The subclavian steal" [editorial]. N Engl J Med 1961, 265:912-913.
199. de Bray JM, Zenglein JP, Laroche JP, et al. Effect of subclavian syndrome on the basilar artery. Acta Neurol Scand 1994, 90:174-178.
200. Herring M The subclavian steal syndrome: A review. Am Surg 1977, 43:220-228.
201. Piccone VA, Leveen HH The subclavian steal syndrome. Ann Thoracic Surg 1970, 9:51-75.
202. Smith JM, Koury HI, Hafner CD, Welling RE Subclavian steal syndrome: A review of 59 consecutive cases. J Cardiovasc Surg (Torino) 1994, 35:11-14.
203. Thomassen L, Aarli JA Subclavian steal phenomenon: Clinical and hemodynamic aspects. Acta Neurol Scand 1994, 90:241-244.
204. Walker PM, Paley D, Harris KA, et al. What determines the symptoms associated with subclavian artery occlusive disease?. J Vasc Surg 1985, 2:154-157.
205. Webster MW, Downs L, Yonas H, et al. The effect of arm exercise on regional cerebral blood flow in the subclavian steal syndrome. Am J Surg 1994, 168:91-93.
206. Fields WS, Lemak NA Joint study of extracranial arterial occlusion. VII: Subclavian steal-a review of 168 cases. JAMA 1972, 222:1139-1143.
207. Ackermann H, Diener HC, Seboldt H, Huth C Ultrasonographic follow-up of subclavian stenosis and occlusion: Natural history and surgical treatment. Stroke 1988, 19:431-435.
208. Drutman J, Gyorke A, Davis WL, Turski PA Evaluation of subclavian steal with two-dimensional phase-contrast and two-dimensional time-of-flight MR angiography. AJNR Am J Neuroradiol 1994, 15:1642-1645.
209. AbuRahma AF, Robinson PA, Jennings TG Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: A 20-year experience. J Vasc Surg 2000, 32:411-419.
210. Beebe HG, Stark R, Johnson ML, et al. Choices of operation for subclavian-vertebral arterial disease. Am J Surg 1980, 139:616-623.
211. Deriu GP, Milite D, Verlato F, et al. Surgical treatment of atherosclerotic lesions of subclavian artery: Carotid-subclavian bypass versus subclavian-carotid transposition. J Cardiovasc Surg (Torino) 1998, 39:729-734.
212. Owens LV, Tinsley EA, Criado E, et al. Extrathoracic reconstruction of arterial occlusive disease involving the supraaortic trunks. J Vasc Surg 1995, 22:217-222.
213. Bachman DM, Kim RM Transluminal dilatation for subclavian steal syndrome. AJR Am J Roentgenol 1980, 135:995-996.
214. Taylor CL, Selman WR, Ratcheson RA Steal affecting the central nervous system. Neurosurgery 2002, 50:679-689.
215. Bornstein NM, Norris JW Subclavian steal: A harmless haemodynamic phenomenon?. Lancet 1986, 2(8502):303-305.
216. Moran KT, Zide RS, Persson AV, Jewell ER Natural history of subclavian steal syndrome. Am Surg 1988, 54:643-644.
217. Hennerici M, Klemm C, Rautenberg W The subclavian steal phenomenon: A common vascular disorder with rare neurologic deficits. Neurology 1988, 38:669-673.
218. Farina C, Mingoli A, Schultz RD, et al. Percutaneous transluminal angioplasty versus surgery for subclavian artery occlusive disease. Am J Surg 1989, 158:511-514.
219. Hebrang A, Maskovic J, Tomac B Percutaneous transluminal angioplasty of the subclavian arteries: Long-term results in 52 patients. AJR Am J Roentgenol 1991, 156:1091-1094.
220. Mathias KD, Luth I, Haarmann P Percutaneous transluminal angioplasty of proximal subclavian artery occlusions. Cardiovasc Intervent Radiol 1993, 16:214-218.
221. Motarjeme A, Keifer JW, Zuska AJ, Nabawi P Percutaneous transluminal angioplasty for treatment of subclavian steal. Radiology 1985, 155:611-613.
222. Selby JB, Matsumoto AH, Tegtmeyer CJ, et al. Balloon angioplasty above the aortic arch: Immediate and long-term results. AJR Am J Roentgenol 1993, 160:631-635.
223. Kumar K, Dorros G, Bates MC, et al. Primary stent deployment in occlusive subclavian artery disease. Cathet Cardiovasc Diagn 1995, 34:281-285.
224. Queral LA, Criado FJ The treatment of focal aortic arch branch lesions with Palmaz stents. J Vasc Surg 1996, 23:368-375.
225. Rodriguez-Lopez JA, Werner A, Martinez R, et al. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg 1999, 13:254-260.
226. Sueoka BL Percutaneous transluminal stent placement to treat subclavian steal syndrome. J Vasc Interv Radiol 1996, 7:351-356.
227. Vitek JJ Subclavian artery angioplasty and the origin of the vertebral artery. Radiology 1989, 170:407-409.
228. Bogey WM, Demasi RJ, Tripp MD, et al. Percutaneous transluminal angioplasty for subclavian artery stenosis. Am Surg 1994, 60:103-106.
229. Ringelstein EB, Zeumer H Delayed reversal of vertebral artery blood flow following percutaneous transluminal angioplasty for subclavian steal syndrome. Neuroradiology 1984, 26:189-198.
230. Weir B Unruptured intracranial aneurysms: A review. J Neurosurg 2002, 96:3-42.
231. de la Monte SM, Moore GW, Monk MA, Hutchins GM Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med 1985, 78:957-964.
232. Inagawa T, Hirano A Autopsy study of unruptured incidental intracranial aneurysms. Surg Neurol 1990, 34:361-365.
233. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993, 78:188-191.
234. Kiyohara Y, Ueda K, Hasuo Y, et al. Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 1989, 20:1150-1155.
235. Sarti C, Tuomilehto J, Salomaa V, et al. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 1991, 22:848-853.
236. Mohr JP, Caplan LR, Melski JW, et al. The Harvard Cooperative Stroke Registry: A prospective registry. Neurology 1978, 28:754-762.
237. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 1998, 339:1725-1733.
238. Qureshi AI, Suri MF, Yahia AM, et al. Risk factors for subarachnoid hemorrhage. Neurosurgery 2001, 49:607-613.
239. Bendok BR, Getch CC, Malisch TW, Batjer HH Treatment of aneurysmal subarachnoid hemorrhage. Semin Neurol 1998, 18:521-531.
240. Malisch TW, Guglielmi G, Vinuela F, et al. Unruptured aneurysms presenting with mass effect symptoms: Response to endosaccular treatment with Guglielmi detachable coils. Part I: Symptoms of cranial nerve dysfunction. J Neurosurg 1998, 89:956-961.
241. Qureshi AI, Mohammad Y, Yahia AM, et al. Ischemic events associated with unruptured intracranial aneurysms: Multicenter clinical study and review of the literature. Neurosurgery 2000, 46:282-290.
242. Mayberg MR, Batjer HH, Dacey R, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 1994, 90:2592-2605.
243. Juvela S Rebleeding from ruptured intracranial aneurysms. Surg Neurol 1989, 32:323-326.
244. Vinuela F, Duckwiler G, Mawad M Guglielmi detachable coil embolization of acute intracranial aneurysm: Perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997, 86:475-482.
245. Biller J, Godersky JC, Adams HP Management of aneurysmal subarachnoid hemorrhage. Stroke 1988, 19:1300-1305.
246. Origitano TC, Reichman OH, Anderson DE Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992, 31:804-806.
247. Newell DW, Eskridge JM, Mayberg MR, et al. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 1989, 71:654-660.
248. Coskun E Papaverine and vasospasm. J Neurosurg 2002, 96:973-974.
249. Morgan MK, Jonker B, Finfer S, et al. Aggressive management of aneurysmal subarachnoid haemorrhage based on a papaverine angioplasty protocol. J Clin Neurosci 2000, 7:305-308.
250. Ohkuma H, Ogane K, Tanaka M, Suzuki S Assessment of cerebral microcirculatory changes during cerebral vasospasm by analyzing cerebral circulation time on DSA images. Acta Neurochir Suppl (Wien) 2001, 77:127-130.
251. Turjman F, Massoud TF, Sayre J, Vinuela F Predictors of aneurysmal occlusion in the period immediately after endovascular treatment with detachable coils: A multivariate analysis. AJNR Am J Neuroradiol 1998, 19:1645-1651.
252. Moret J, Cognard C, Weill A, et al. Reconstruction technic in the treatment of wide-neck intracranial aneurysms: Long-term angiographic and clinical results. Apropos of 56 cases. J Neuroradiol 1997, 24:30-44.
253. Lanzino G, Wakhloo AK, Fessler RD, et al. Efficacy and current limitations of intravascular stents for intracranial internal carotid, vertebral, and basilar artery aneurysms. J Neurosurg 1999, 91:538-546.
254. Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: A statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001, 32:1458-1471.
255. Chiaradio JC, Guzman L, Padilla L, Chiaradio MP Intravascular graft stent treatment of a ruptured fusiform dissecting aneurysm of the intracranial vertebral artery: Technical case report. Neurosurgery 2002, 50:213-216. discussion 216-217.
256. Berger MS, Wilson CB Intracranial dissecting aneurysms of the posterior circulation: Report of six cases and review of the literature. J Neurosurg 1984, 61:882-894.
257. Ali MA, Bendok BR, Tawk RG, et al. Trapping and revascularization for a dissecting aneurysm of the proximal posteroinferior cerebellar artery: Technical case report and review of the literature. Neurosurgery 2002, 51:258-263.
258. Michelson W Natural history and pathophysiology of arteriovenous malformations. Clin Neurosurg 1978, 26:307-313.
259. Jessurun GA, Kamphuis DJ, van der Zande FH, Nossent JC Cerebral arteriovenous malformations in The Netherlands Antilles: High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg 1993, 95:193-198.
260. Patterson J, McKossoch W A clinical survey of intracranial angiomas with special reference to their mode of progression and surgical treatment: A report of 110 cases. Brain 1956, 79:233-266.
261. Lasjaunias P, Piske R, Terbrugge K, Willinsky R Cerebral arteriovenous malformations (C. AVM) and associated arterial aneurysms (AA). Analysis of 101 C. AVM cases, with 37 AA in 23 patients. Acta Neurochir 1988, 91:29-36.
262. Spetzler RF, Martin NA A proposed grading system for arteriovenous malformations. J Neurosurg 1986, 65:476-483.
263. Hartmann A, Pile-Spellman J, Stapf C, et al. Risk of endovascular treatment of brain arteriovenous malformations. Stroke 2002, 33:1816-1820.
264. Furlan AJ, Whisnant JP, Elveback LR The decreasing incidence of primary intracerebral hemorrhage: A population study. Ann Neurol 1979, 5:367-373.
265. Brown RD, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988, 68:352-357.
266. Fults D, Kelly DL Natural history of arteriovenous malformations of the brain: A clinical study. Neurosurgery 1984, 15:658-662.
267. Graf CJ, Perret GE, Torner JC Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983, 58:331-337.
268. Ondra SL, Troupp H, George ED, Schwab K The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg 1990, 73:387-391.
269. Hartmann A, Mast H, Mohr JP, et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998, 29:931-934.
270. Kondziolka D, McLaughlin MR, Kestle JR Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery 1995, 37:851-855.
271. Forster DM, Steiner L, Hakanson S Arteriovenous malformations of the brain: A long-term clinical study. J Neurosurg 1972, 37:562-570.
272. Kader A, Young WL, Pile-Spellman J, et al. The influence of hemodynamic and anatomic factors on hemorrhage from cerebral arteriovenous malformations. Neurosurgery 1994, 34:801-808.
273. Miyasaka Y, Yada K, Ohwada T, et al. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J Neurosurg 1992, 76:239-243.
274. Heros RC, Korosue K, Diebold PM Surgical excision of cerebral arteriovenous malformations: Late results. Neurosurgery 1990, 26:570-578.
275. Jafar JJ, Davis AJ, Berenstein A, et al. The effect of embolization with N-butyl cyanoacrylate prior to surgical resection of cerebral arteriovenous malformations. J Neurosurg 1993, 78:60-69.
276. Spetzler RF, Wilson CB, Weinstein P, et al. Normal perfusion pressure breakthrough theory. Clin Neurosurg 1978, 25:651-672.
277. Pollock BE, Lunsford LD, Flickinger JC, Kondziolka D The role of embolization in combination with stereotactic radiosurgery in the management of pial and dural arteriovenous malformations. Interventional Neuroradiology 1999, 267-275. WB Saunders, Philadelphia. J.J. Connors, J.C. Wojak (Eds.).
278. Fournier D, TerBrugge KG, Willinsky R, et al. Endovascular treatment of intracerebral arteriovenous malformations: Experience in 49 cases. J Neurosurg 1991, 75:228-233.
279. Gobin YP, Laurent A, Merienne L, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg 1996, 85:19-28.
280. Vinuela F, Dion JE, Duckwiler G, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: Experience with 101 cases. J Neurosurg 1991, 75:856-864.
281. Debrun GM, Aletich V, Ausman JI, et al. Embolization of the nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997, 40:112-121.
282. Hekster RE, Matricali B, Luyendijk W Presurgical transfemoral catheter embolization to reduce operative blood loss: Technical note. J Neurosurg 1974, 41:396-398.
283. Berenstein A, Russell E Gelatin sponge in therapeutic neuroradiology: A subject review. Neuroradiology 1981, 141:105-112.
284. Brismar J, Cronqvist S Therapeutic embolization in the external carotid artery region. Acta Radiol Diagn (Stockh) 1978, 19:715-731.
285. Hieshima GB, Everhart FR, Mehringer CM, et al. Preoperative embolization of meningiomas. Surg Neurol 1980, 14:119-127.
286. Hilal SK, Michelsen JW Therapeutic percutaneous embolization for extra-axial vascular lesions of the head, neck, and spine. J Neurosurg 1975, 43:275-287.
287. Latchaw RE, Gold LH Polyvinyl foam embolization of vascular and neoplastic lesions of the head, neck, and spine. Radiology 1979, 131:669-679.
288. Feun LG, Wallace S, Stewart DJ, et al. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 1984, 54:794-799.
289. Qureshi AI, Suri MF, Khan J, et al. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: Experience in 100 procedures. J Neurooncol 2001, 51:151-158.
290. Recht L, Fram RJ, Strauss G, et al. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (CDDP) and i.v. BCNU: A phase II trial. Am J Clin Oncol 1990, 13:125-131.
291. Stewart DJ, Grahovac Z, Benoit B, et al. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4Ξ- O-demethyl-1- O-(4,6- O-2-thenylidene-β- d-glucopyranosyl)epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumors. Neurosurgery 1984, 15:828-833.
292. Watne K, Hannisdal E, Nome O, et al. Combined intra-arterial and systemic chemotherapy for recurrent malignant brain tumors. Neurosurgery 1992, 30:223-227.
293. Kerber CW, Wong WH, Howell SB, et al. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. AJNR Am J Neuroradiol 1998, 19:935-941.
294. Bendszus M, Rao G, Burger R, et al. Is there a benefit of preoperative meningioma embolization?. Neurosurgery 2000, 47:1306-1312.
295. Bendszus M, Klein R, Burger R, et al. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol 2000, 21:255-261.
296. Kai Y, Hamada J, Morioka M, et al. Appropriate interval between embolization and surgery in patients with meningioma. AJNR Am J Neuroradiol 2002, 23:139-142.
297. Kuroiwa T, Tanaka H, Ohta T, Tsutsumi A Preoperative embolization of highly vascular brain tumors: Clinical and histopathological findings. Noshuyo Byori 1996, 13:27-36.
298. Jüngling FD, Wakhloo AK, Hennig J In vivo proton spectroscopy of meningioma after preoperative embolization. Magn Reson Med 1993, 30:155-160.
299. Horowitz MB, Spiro R, Purdy P, et al. Meningioma embolization. Contemp Neurosurg 2001, 23:1-6.
300. Suyama T, Tamaki N, Fujiwara K, et al. Peritumoral and intratumoral hemorrhage after gelatin sponge embolization of malignant meningioma: Case report. Neurosurgery 1987, 21:944-946.
301. Terada T, Nakai E, Tsumoto T, Itakura T Iatrogenic arteriovenous fistula of the middle meningeal artery caused during embolization for meningioma-case report. Neurol Med Chir (Tokyo) 1997, 37:677-680.
302. Niranjan A, Lunsford LD, Gobbel GT, et al. Brain tumor radiosurgery: Current status and strategies to enhance the effect of radiosurgery. Brain Tumor Pathol 2000, 17:89-96.
303. Niranjan A, Moriuchi S, Lunsford LD, et al. Effective treatment of experimental glioblastoma by HSV vector-mediated TNFalpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration. Mol Ther 2000, 2:114-120.
304. Radford IR Gd-Tex Pharmacyclics Inc. Curr Opin Investig Drugs 2000, 1:524-528.
305. Rosenthal DI, Nurenberg P, Becerra CR, et al. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging. Clin Cancer Res 1999, 5:739-745.